glp-1 availability Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Medications Near Me in

These results were published in The Lancet

The adoption of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) has skyrocketed over the past few years, ushering in a new era of weight management and type 2 diabetes mellitus (T2DM) care

In the SURMOUNT-1 trial, 95 percent of participants taking tirzepatide reverted to normal blood sugar over 176 weeks, and 99 percent stayed diabetes-free

Some people may experience sulfur burps, while others do not, and the absence or presence of this symptom does not correlate with how well the drug is controlling blood sugar or supporting weight loss

Stevens JC, Sun S, Beard CM, et al